MedTrace Logo

Presepsin as a Predictor for Postoperative Complications Following Pancreatic Resection

NCT04294797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2020-03-04

No results posted yet for this study

Summary

The study investigates the local and systemic inflammatory response following pancreatic resections.

Conditions

  • Postoperative Complications

Interventions

DIAGNOSTIC_TEST

Blood draw

One additional blood sample for study purpose from the day before surgery, postoperative 1, 3 and 8.

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-11
Primary Completion
2019-08-26
Completion
2019-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04294797 on ClinicalTrials.gov